Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams

March 3, 2000

ADIR's new MMP inhibitors particularly useful for cancer, rheumatoid arthritis

March 3, 2000

Pharmachemie presents new water-soluble tin compounds with excellent antitumor activity

March 3, 2000

CryoLife and Viragen enter cancer therapy collaboration

March 3, 2000

IL-4 gene therapy studied in malignant glioma

March 3, 2000

Maxygen enters CRADA with NCI for anticancer proteins

March 2, 2000

Several new approvals obtained for Gliadel

March 2, 2000

Feasibility of HSV-TK/GCV gene therapy demonstrated in glioblastoma multiforme

March 2, 2000

Aptosyn/Gemzar cancer trials to begin shortly

March 2, 2000

VEGF-targeted antisense oligonucleotides inhibit tumor growth

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026